1-8 of 8
home therapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subcutaneous Immunoglobulin (SCIG) in Responders to Intravenous Therapy with Chronic Immune Thrombocytopenia (ITP)

Francesco Iuliano, MD, Eleonora Iuliano, MD, Maria Luci, MD, Alessia Perricelli, MD, Angelo Pomillo, MD, Elisabetta Abruzzese
Journal: Blood
Blood (2014) 124 (21): 5012.
https://doi.org/10.1182/blood.V124.21.5012.5012
Published: 2014
Journal Articles

Determinants Of Cost Of Care For Persons With Severe Hemophilia

Michael W. Evans, MD, MPH, M. Elaine Eyster, MD, Christopher S. Hollenbeak, PhD
Journal: Blood
Blood (2013) 122 (21): 2969.
https://doi.org/10.1182/blood.V122.21.2969.2969
Published: 2013
Journal Articles

Report on the Safety of Velaglucerase Alfa Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease and the Transition From Clinic to Home Infusions During Treatment Protocol HGT-GCB-058

Gregory M Pastores, Barry E Rosenbloom, MD, Neal J Weinreb, Ozlem Goker-Alpan, Rebecca Mardach, Mark Lipson, Jennifer Ibrahim, Gabriel M Cohn, David Zahrieh, Pramod K Mistry
Journal: Blood
Blood (2011) 118 (21): 1101.
https://doi.org/10.1182/blood.V118.21.1101.1101
Published: 2011
Journal Articles

Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience

Clinical Trials & Observations
Ari Zimran, Gheona Altarescu, Mici Philips, Drorit Attias, Marina Jmoudiak, Maher Deeb, Nan Wang, Kiran Bhirangi, Gabriel M. Cohn, Deborah Elstein
Journal: Blood
Blood (2010) 115 (23): 4651–4656.
https://doi.org/10.1182/blood-2010-02-268649
Published: 2010
Journal Articles

Strategies for Securing and Maintaining Predictable Efficacy with Recombinant Activated Factor VII in On-Demand Treatment of Haemophilia Patients with Inhibitors.

Benny Sørensen, MD, Ph.D., Yesim Dargaud, Gili Kenet, MD, PhD, Jeanne M. Lusher, MD, Andrew Mumford, Steven W. Pipe, MD, Andreas Tiede, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4443.
https://doi.org/10.1182/blood.V114.22.4443.4443
Published: 2009
Journal Articles

Use of Single Dose of rFVIIa in Congenital Hemophilia: Analysis of Data Capture from the Hemophilia and Thrombosis Research Society Registry (2004–2008)

Nigel S Key, MB, ChB, Joan Cox Gill, MD, Craig M. Kessler, MD, Caitlyn T. Wilke, David L. Cooper, MD, MBA, HRS HTRS Investigators
Journal: Blood
Blood (2008) 112 (11): 4509.
https://doi.org/10.1182/blood.V112.11.4509.4509
Published: 2008
Journal Articles

Similarity in Joint Function Limitation in Type 3 VWD and Moderate Hemophilia A

Suman Sood, MD, Adam Cuker, MD, Chengbin Wang, Ph.D., Ara Metjian, MD, Elaine Y Chiang, J. Michael Soucie, Ph.D., Barbara A. Konkle, MD, Htcn Investigators
Journal: Blood
Blood (2008) 112 (11): 426.
https://doi.org/10.1182/blood.V112.11.426.426
Published: 2008
Journal Articles

Subcutaneous Immunoglobulin Substitutions in Previously Untreated (PUPs) and Treated Patients (PTPs) Result in Rapid Improvement of Total and Serum IgG Levels - a Novel Substitution Protocol for PUPs.

Christoph Königs, Dominik Dunsch, Richard Linde, Thomas Klingebiel, Prof, Dr, Wolfhart Kreuz, PD
Journal: Blood
Blood (2004) 104 (11): 3832.
https://doi.org/10.1182/blood.V104.11.3832.3832
Published: 2004